Table 1 Number of cholangiocarcinoma (CCA; “positive”) and non-CCA (“negative”) cells captured from two technical replicates (i.e., bile aliquots) from each of eight CCA patients with the on-chip CCA diagnostics system.
From: A Microfluidic Chip for Detecting Cholangiocarcinoma Cells in Human Bile
Patient No. | Diagnosis | Captured positive cells (#) | Captured negative cells (#) |
|---|---|---|---|
01 | Liver hilar tumor/CCA (stage IV) | 3.6 ± 1.3 | 5.4 ± 3.7 |
02 | CCA with lung metastases (stage IV) | 1.3 ± 1.5 | 2.3 ± 1.5 |
03 | Gallbladder cancer with lung metastases (stage IV) | 3.0 ± 1.4 | 2.5 ± 0.7 |
04 | Recurrent CCA (liver metastasis; stage IV) | 2.8 ± 1.3 | 3.0 ± 2.5 |
05 | Intrahepatic CCA (stage III) | 3.3 ± 1.5 | 2.3 ± 2.1 |
06 | CCA with peritoneal carcinomatosis (stage IV) | 3.5 ± 0.7 | 0.0 ± 0.0 |
07 | Malignant neoplasm of intrahepatic bile ducts (stage III) | 2.3 ± 2.3 | 1.0 ± 0.0 |
08 | CCA stage IIIb (after chemotherapy) | 0.0 ± 0.7 | 1.0 ± 0.8 |
09 | Non-cancer patient (cholecystitis) | 0.0 ± 0.0 | 2.0 ± 0.5 |
10 | Non-cancer patient (cholecystitis) | 0.0 ± 0.3 | 1.3 ± 0.1 |
